BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19326058)

  • 1. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.
    Jimenez-Zepeda VH; Dominguez-Martinez VJ
    Int J Hematol; 2009 Apr; 89(3):259-268. PubMed ID: 19326058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A; Zawirska D; Skotnicki AB
    Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia.
    Gentry M; Pettenati M; Pang CS
    Int J Clin Exp Pathol; 2013; 6(10):2224-9. PubMed ID: 24133602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell leukemia: from biology to treatment.
    Jelinek T; Kryukov F; Rihova L; Hajek R
    Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
    Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
    Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell leukemia.
    Albarracin F; Fonseca R
    Blood Rev; 2011 May; 25(3):107-12. PubMed ID: 21295388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.
    Zatula A; Dikic A; Mulder C; Sharma A; Vågbø CB; Sousa MML; Waage A; Slupphaug G
    Oncotarget; 2017 Mar; 8(12):19427-19442. PubMed ID: 28038447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH; Domínguez VJ
    Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
    Gangadhar P; Ahmed Z; Pai MR; Sandhya I
    Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Li JY; Morineau N; Facon T; Brigaudeau C; Harousseau JL; Grosbois B; Bataille R
    Blood; 1999 Oct; 94(8):2583-9. PubMed ID: 10515861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent upregulation of MYC in plasma cell leukemia.
    Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles.
    Mosca L; Musto P; Todoerti K; Barbieri M; Agnelli L; Fabris S; Tuana G; Lionetti M; Bonaparte E; Sirchia SM; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omedè P; Boccadoro M; Palumbo A; Neri A
    Am J Hematol; 2013 Jan; 88(1):16-23. PubMed ID: 23044976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.
    Mateos MV; Garcia-Sanz R; López-Pérez R; Balanzategui A; González MI; Fernández-Calvo J; Moro MJ; Hernández J; Caballero MD; González M; San Miguel JF
    Hematol J; 2001; 2(3):146-9. PubMed ID: 11920239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
    Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
    Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aberrations and survival in plasma cell leukemia.
    Tiedemann RE; Gonzalez-Paz N; Kyle RA; Santana-Davila R; Price-Troska T; Van Wier SA; Chng WJ; Ketterling RP; Gertz MA; Henderson K; Greipp PR; Dispenzieri A; Lacy MQ; Rajkumar SV; Bergsagel PL; Stewart AK; Fonseca R
    Leukemia; 2008 May; 22(5):1044-52. PubMed ID: 18216867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.